PMID- 37620614 OWN - NLM STAT- MEDLINE DCOM- 20231115 LR - 20231122 IS - 2509-2723 (Electronic) IS - 2509-2715 (Print) IS - 2509-2723 (Linking) VI - 45 IP - 6 DP - 2023 Dec TI - Association between aging-related biomarkers and longitudinal trajectories of intrinsic capacity in older adults. PG - 3409-3418 LID - 10.1007/s11357-023-00906-2 [doi] AB - Intrinsic capacity (IC), the composite of physical and mental capacities, declines with age at different rates and patterns between individuals. We aimed to investigate the association between longitudinal IC trajectories and plasma biomarkers of two hallmarks of aging-chronic inflammation and mitochondrial dysfunction-in older adults. From the Multidomain Alzheimer Preventive Trial (MAPT), we included 1271 community-dwelling older people (mean [SD] age = 76.0 [4.3] years) with IC data over four years. Group-based multi-trajectory modeling was performed to identify clusters of the participants with similar longitudinal patterns across four IC domains: cognition, locomotion, psychology, and vitality. Five IC multi-trajectory groups were determined: low in all domains (8.4%), low locomotion (24.6%), low psychological domain (16.7%), robust (i.e., high in all domains except vitality; 28.3%), and robust with high vitality (22.0%). Compared to the best trajectory group (i.e., robust with high vitality), elevated levels of plasma interleukin-6 (IL-6), tumor necrosis factor receptor-1 (TNFR-1), and growth differentiation factor-15 (GDF-15) were associated with a higher risk of belonging to the "low in all domains" group (IL-6: relative risk ratio (RRR) [95% CI] = 1.42 [1.07 - 1.88]; TNFR-1: RRR = 1.46 [1.09 - 1.96]; GDF-15: RRR = 1.99 [1.45 - 2.73]). Higher IL-6 and GDF-15 also increased the risk of being in the "low locomotion" group. GDF-15 outperformed other biomarkers by showing the strongest associations with IC trajectory groups. Our findings found that plasma biomarkers reflecting inflammation and mitochondrial impairment distinguished older people with multi-impaired IC trajectories from those with high-stable IC. CI - (c) 2023. The Author(s), under exclusive licence to American Aging Association. FAU - Lu, Wan-Hsuan AU - Lu WH AUID- ORCID: 0000-0001-7824-4214 AD - Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), 31000, Toulouse, France. wan-hsuan.lu1@univ-tlse3.fr. AD - Maintain Aging Research team, Centre d'Epidemiologie et de Recherche en sante des POPulations (CERPOP), Inserm, Universite Paul Sabatier, Toulouse, France. wan-hsuan.lu1@univ-tlse3.fr. FAU - Guyonnet, Sophie AU - Guyonnet S AD - Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), 31000, Toulouse, France. AD - Maintain Aging Research team, Centre d'Epidemiologie et de Recherche en sante des POPulations (CERPOP), Inserm, Universite Paul Sabatier, Toulouse, France. FAU - Martinez, Laurent O AU - Martinez LO AD - Institut National de la Sante et de la Recherche Medicale (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. FAU - Lucas, Alexandre AU - Lucas A AD - Institut National de la Sante et de la Recherche Medicale (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. FAU - Parini, Angelo AU - Parini A AD - Institut National de la Sante et de la Recherche Medicale (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France. FAU - Vellas, Bruno AU - Vellas B AD - Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), 31000, Toulouse, France. AD - Maintain Aging Research team, Centre d'Epidemiologie et de Recherche en sante des POPulations (CERPOP), Inserm, Universite Paul Sabatier, Toulouse, France. FAU - de Souto Barreto, Philipe AU - de Souto Barreto P AD - Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), 31000, Toulouse, France. AD - Maintain Aging Research team, Centre d'Epidemiologie et de Recherche en sante des POPulations (CERPOP), Inserm, Universite Paul Sabatier, Toulouse, France. LA - eng PT - Journal Article DEP - 20230824 PL - Switzerland TA - Geroscience JT - GeroScience JID - 101686284 RN - 0 (Growth Differentiation Factor 15) RN - 0 (Interleukin-6) RN - 0 (Biomarkers) SB - IM MH - Humans MH - Aged MH - *Growth Differentiation Factor 15 MH - *Alzheimer Disease/psychology MH - Interleukin-6 MH - Prospective Studies MH - Aging MH - Biomarkers MH - Inflammation PMC - PMC10643641 OTO - NOTNLM OT - Biological aging OT - Functioning OT - Healthy aging OT - Inflammaging COIS- The authors declare no competing interests. EDAT- 2023/08/25 00:42 MHDA- 2023/11/15 06:43 PMCR- 2023/08/24 CRDT- 2023/08/24 23:36 PHST- 2023/06/23 00:00 [received] PHST- 2023/08/06 00:00 [accepted] PHST- 2023/11/15 06:43 [medline] PHST- 2023/08/25 00:42 [pubmed] PHST- 2023/08/24 23:36 [entrez] PHST- 2023/08/24 00:00 [pmc-release] AID - 10.1007/s11357-023-00906-2 [pii] AID - 906 [pii] AID - 10.1007/s11357-023-00906-2 [doi] PST - ppublish SO - Geroscience. 2023 Dec;45(6):3409-3418. doi: 10.1007/s11357-023-00906-2. Epub 2023 Aug 24.